BioMed Realty Appoints Marie Lewis as Executive Vice President and General Counsel

The promotion highlights Ms. Lewis’ decade of commitment to the Company’s success and further strengthens the Company’s executive leadership team

SAN DIEGO--(BUSINESS WIRE)--BioMed Realty, a leading provider of real estate solutions to the life science and technology industries, announced the appointment of Marie Lewis to Executive Vice President and General Counsel.

Ms. Lewis joined the company in 2013 as Managing Attorney for the Real Estate Legal Department. During her tenure, Ms. Lewis has taken on increasing levels of responsibility and has been instrumental to BioMed Realty’s growth and success, playing a critical role in many significant transactions that have shaped the Company’s expanding footprint. In February 2022, Ms. Lewis joined the executive team when she became responsible for the Integration and Communications functions, and she has also acted as interim General Counsel since early 2023. Ms. Lewis was appointed Executive Vice President and General Counsel effective October 1, 2023, and will be responsible for the Company’s Legal, Integration and Communications functions.

“This promotion affirms the impact that Marie has had on the BioMed Realty franchise over the past decade,” said Tim Schoen, CEO of BioMed Realty. “Marie’s continued dedication to excellence, her passion for the Company’s vision, and her talent as a committed mentor and leader have laid the groundwork for her success at the Company. I am confident she will bring the same commitment to her newly expanded role.”

Ms. Lewis has a rich history of real estate industry experience, having joined BioMed Realty from Sempra Energy, where she held the role of Managing Attorney, Real Estate. Prior to Sempra Energy, she was an associate at Gibson, Dunn & Crutcher LLP. Ms. Lewis graduated cum laude from Loyola Law School in Los Angeles and clerked for Judge William J. Rea in the Central District of California.

About BioMed Realty

BioMed Realty, a Blackstone portfolio company, is a leading provider of real estate solutions to the life science and technology industries. As of June 30, 2023, BioMed Realty owned and operated high quality life science real estate comprising 16.7 million square feet concentrated in leading innovation markets throughout the United States and the United Kingdom, including Boston/Cambridge, San Francisco, San Diego, Seattle, Boulder and Cambridge, U.K. In addition, the Company maintains a premier development platform with 3.3 million square feet of Class A properties in active construction in these core innovation markets to meet the growing demand of the life science and technology industries. To learn more about BioMed Realty, visit biomedrealty.com and follow the company on X @biomedrealty.